Empowering Advanced Practice Providers to Adopt Routine Scre

Tardive dyskinesia (TD) is an involuntary movement disorder associated with prolonged use of dopamine receptor blocking agents (DRBAs) that can range in severity and presentation and can impact social, emotional, and functional components of daily life. There are treatments that can effectively manage TD, but first it needs to be recognized and accurately diagnosed.

Related Keywords

United States , San Diego , California , American , Amy Lacouture , Linda Trinh , Goodman Gilman , Psychopharmacology Research Branch , Neurocrine Biosciences Inc , Mental Health Administration , National Institute Of Mental Health , Mcgraw Hill , Drug Administration , Division Of Extramural Research Programs , Abnormal Involuntary Movement Scale , American Psychiatric Association , Public Health Service , Society Of Biological Psychiatry Annual Meeting , Neuroscience Education Institute Congress , Neurocrine Biosciences , Increase Routine , Differential Diagnosis , Important Safety Information , Boxed Warning , Increased Vigilance Among Advanced Practice , Neuroleptic Malignant Syndrome , Prescribing Information , Spec Issue , Statistical Manual , Psychiatric Association , Treat Options , Patient Rep , Patients With , Colorado Springs , Drug Abuse , National Institute , Mental Health , Extramural Research Programs , Pharmacological Basis , Graw Hill , Pharmacol Exp , Biological Psychiatry Annual Meeting , All Rights ,